Analyst Reco. BeiGene, Ltd. Deutsche Boerse AG

Equities

49B

KYG1146Y1017

Market Closed - Deutsche Boerse AG Other stock markets 02:20:01 2024-05-15 am EDT			After market 04:00:25 pm
11.5 ^EUR	0.00%		11.75	+2.17%

May. 09	Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up	MT
May. 08	Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BeiGene to Award Shares Worth $15 Million to 11 Directors	Apr. 17	MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	Apr. 11	MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	Apr. 11	MT
Bernstein Adjusts BeiGene's Price Target to $161 From $196, Maintains Market Perform Rating	Mar. 27	MT
Nomura Adjusts Beigene’s Price Target to HK$150.60 From HK$162.05, Keeps at Buy	Feb. 22	MT
Nomura Adjusts BeiGene Price Target to $268.36 From $253.14, Maintains Buy Rating	Nov. 07	MT
Citigroup Lowers Price Target on BeiGene to $285 From $290, Maintains Buy Rating	23-10-26	MT
Future Rate Hike Fears Bring Hong Kong Stocks to Slump; BeiGene Slips 7%	23-09-21	MT
Citigroup Raises BeiGene Price Target to $290 From $285, Maintains Buy Rating	23-09-20	MT
Macquarie Starts BeiGene at Outperform, $259 Price Target	23-09-12	MT
Morgan Stanley Adjusts BeiGene's Price Target to $319 From $321, Keeps Overweight Rating	23-08-29	MT
Jefferies Starts BeiGene at Buy With $287 Price Target	23-08-17	MT
JPMorgan Chase Adjusts Price Target on BeiGene to $300 From $297, Maintains Overweight Rating	23-08-07	MT
Nomura Adjusts BeiGene Price Target to $253.14 From $309.47, Maintains Buy Rating	23-07-20	MT
Nomura Adjusts BeiGene's Price Target to HK$152.86 From HK$186.87, Keeps at Buy	23-07-20	MT
Citigroup Initiates BeiGene With Buy Rating, $275 Price Target	23-07-17	MT
Bernstein Downgrades BeiGene to Market Perform From Outperform, Cuts Price Target to $196 From $335	23-06-30	MT
Nomura Adjusts BeiGene's Price Target to HK$186.87 From HK$172.81, Keeps at Buy	23-05-05	MT
Nomura Adjusts BeiGene Price Target to $309.47 From $286.19, Maintains Buy Rating	23-05-05	MT
Morgan Stanley Adjusts Price Target on BeiGene to $321 From $325, Maintains Overweight Rating	23-02-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. BeiGene, Ltd. Deutsche Boerse AG

Equities

49B

KYG1146Y1017

Analyst Reco.

Filters